Walter and Eliza Hall Institute is a very reputable institution to do these studies. I think a breakthrough from PAA on COVID-19 is a long shot. Worth checking but not worth losing sight of the company's predominant focus and potential - cancer.
Ann: PharmAust to Evaluate Monepantel on COVID-19, page-4
-
- There are more pages in this discussion • 312 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $77.79M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.5¢ | $244.5K | 1.554M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 306564 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 46887 | 3 |
View Market Depth
| Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |